|
HS Code |
306470 |
As an accredited 7-Bromo-1H-Indazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 7-Bromo-1H-Indazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
I remember the first time I came across 7-Bromo-1H-Indazole in the lab. The name itself sounded like something out of a technical manual, but there’s real value to this compound that extends beyond its chemical formula. Let’s dig into what makes this molecule tick, how it’s different from the rest of the indazoles out there, and why researchers have been paying closer attention lately.
Chemistry can seem a bit dry if you get bogged down in technical jargon, but it comes alive once you start asking practical questions. In the case of 7-Bromo-1H-Indazole, what stands out is its unique arrangement of bromine on the indazole ring. The parent indazole structure forms the backbone for a range of bioactive molecules, from pharmaceuticals to specialty materials. Introducing a bromine atom in the seventh position changes both the reactivity and the range of applications. Unlike the unsubstituted indazoles or those with other substituents, this compound lets chemists move in a few distinct directions, laying the groundwork for targeted research.
The chemical model of 7-Bromo-1H-Indazole isn’t something that hinges only on theory. It’s listed by chemists as C7H5BrN2, indicating one bromine atom sits on the seventh carbon of the indazole core. From working with this compound, I’ve noticed that bromine adds a bit of heft—raising the molecular weight—and also makes the molecule more reactive in certain coupling reactions. For people synthesizing analogs or building blocks, this structural tweak becomes a launch pad for further chemical innovation.
Anyone who’s spent time in a lab will tell you that synthetic routes often hit a wall because of limitations in available building blocks. 7-Bromo-1H-Indazole opens fresh pathways, especially for those focused on heterocyclic chemistry. I’ve personally used it in Suzuki-Miyaura cross-coupling reactions, where the presence of bromine simplifies introduction of new carbon-carbon bonds. The site-selectivity helps cut down on side reactions, saving time and money.
Researchers in the pharmaceutical sector often turn to indazole derivatives when chasing new kinase inhibitors or tweaking existing candidates for improved potency. What stands out for 7-Bromo-1H-Indazole is its compatibility with a broad set of substituents, so one can generate libraries of analogs with relative ease. This adaptability works well in hit-to-lead processes, where speed and variety matter. Most of the notable kinase inhibitors, from my experience reading the literature, trace their roots to clever manipulations of indazole rings.
Comparing this compound with something like 4-chloroindazole or 6-methoxyindazole, the landscape shifts. Bromine acts as a robust leaving group, making it more reliable for various coupling methodologies. In other words, you get cleaner transformations and more predictable scaling from milligram to gram quantities. Not many indazole derivatives can claim similar versatility across both lab-scale and industrial settings.
I've seen firsthand how the purity of 7-Bromo-1H-Indazole can make or break a project. Minor impurities in reagents can slip through and complicate downstream reactions, leading to headaches during both analysis and purification. Reputable suppliers now specify purity levels above 98%, which lets users focus on their main workflows instead of troubleshooting unexpected results. In my experience, even a shift of one or two percent in reagent quality can snowball into hours of extra work.
Many graduate students I’ve mentored have run into problems when starting with questionable material. With 7-Bromo-1H-Indazole, I’ve noticed that products sourced from established suppliers come out as off-white to pale yellow powders, free from any lingering smells or unusual particulates. Simple but vital details like this help set expectations, because material that looks, smells, or feels off tends to give trouble later on. Analytical data, such as NMR and HPLC, generally supports the listed purity claims, which gives a sense of trust when planning multi-step syntheses.
If you line up the family of indazoles for a close inspection, each substitute brings its own behavior. Adding a bromine at the seventh position makes the molecule more receptive to current synthetic methodologies compared to chloro or fluoro variants. I’ve found that brominated indazoles generally react faster and under milder conditions in palladium-catalyzed cross-couplings. This opens the door to a wider array of modifications, making the workflow less time-sensitive or temperature-dependent.
Some may not see this subtle difference as consequential, but anyone working with tight timelines or limited funding knows that each shortcut can add up. For example, a 6-chloro-1H-indazole might struggle in certain transformations, forcing repetition or lengthy optimization. 7-Bromo-1H-Indazole, by contrast, often makes it through the same steps with more consistent yields. This isn’t just a win for academic labs with small budgets—it means less chemical waste, easier scale-up, and a tighter process in industrial settings.
Everything in the lab comes with its own set of risks, and 7-Bromo-1H-Indazole is no exception. Most indazole derivatives aren’t acutely hazardous, but it pays to treat them with respect. I’ve always advocated for latex or nitrile gloves and standard protective equipment. The dust can be a bit irritating if inhaled or if it gets on exposed skin, but nothing extreme if handled with standard common-sense precautions. While I can’t recall any major episodes stemming from this compound, I’ve always stressed that lab safety starts with basic hygiene and keeping containers closed.
Not all researchers are chemical hygiene enthusiasts, yet they quickly learn that prevention beats cure, especially when working with brominated aromatics. Waste disposal is pretty straightforward—no specialized containers are needed if you’re already handling other halogenated organics responsibly. If any spillage occurs, a quick wipe with damp cloth usually does the trick, assuming everyone’s wearing goggles and gloves. Many underestimate bromine’s tendency for subtlety; it won’t knock you over with fumes, but staying vigilant keeps everyone out of trouble.
From a scientific standpoint, 7-Bromo-1H-Indazole punches above its weight. In my career, I’ve seen it pop up in medicinal chemistry, materials science, and method development. The consistent demand circles back to versatility. Once you’ve made your core scaffold, turning it into something entirely different is a matter of swapping the bromine for another group—phenyl, alkynyl, pyridyl, you name it.
In academia, students often use it as a test case for new catalytic systems, because they can reliably get clean conversions and straightforward product analysis. I remember one summer working on ligand screening. We chose 7-Bromo-1H-Indazole as our model substrate, not because it was the only option, but because it gave clear answers about the performance of each catalyst. In industry, reactions tend to be scaled, so any improvement in yield or selectivity brings savings right to the balance sheet. In short, this molecule lets both students and professionals shine by removing some of the unnecessary mess that comes with less cooperative chemicals.
The recent uptick in research involving this compound doesn’t come as a surprise to anyone who follows pharmaceutical patents. Molecular modeling efforts have highlighted indazole rings as privileged scaffolds for a range of biological targets. These include kinases, phosphodiesterases, and even new territories like antimicrobial peptides. Adding a bromine doesn’t just result in a different flavor; it affects binding affinity, selectivity, and metabolic stability in many of these systems.
For anyone following the drug discovery pipeline, it’s worth noting that the move toward fragment-based and structure-guided techniques puts a premium on adaptable cores. Bromine at position seven expands that versatility, both because of its size (handy for probing binding pockets) and because you can replace it in later steps without harsh conditions. Researchers have built libraries with 7-Bromo-1H-Indazole at the heart of their virtual screens, then later tweak substitutions once promising hits are identified. This approach speeds up the finding of leads and improves the odds of clinical translation.
Beyond the pharmaceutical arena, a few materials science projects have leveraged this molecule for optoelectronic properties or as part of organic semiconductors. The combination of the indazole nitrogen and the electron-withdrawing bromine helps tune both photophysical and electronic characteristics. While this field isn’t as crowded as medicinal chemistry, early results suggest an edge for custom fluorophores or new organic field-effect transistors.
With all its positives, no molecule is a silver bullet. 7-Bromo-1H-Indazole does have quirks that scientists run into. One regular complaint I’ve heard (and experienced) involves solubility. It’s not the most water-friendly compound, often requiring organic solvents like DMF, DMSO, or acetonitrile to fully dissolve. For those running aqueous phase or biocompatible screening, extra prep work is needed, sometimes including the use of cyclodextrins or surfactants.
Stability is another topic. In its neat form, 7-Bromo-1H-Indazole holds up under a range of storage conditions, but certain reaction mixtures—especially those with strong acids or bases—can lead to decomposition or unexpected side reactions. One summer, we lost an entire batch after leaving it in a basic methanol solution too long, driving home the need for proper planning and short residence times. Reliable companies provide careful documentation of stability under common synthetic conditions, helping avoid those costly mishaps.
One way to smooth out the pain points has centered on formulation science. Micronized forms and more robust packaging cut down on waste and loss, especially in humid regions or labs without tight climate control. Some technical teams run regular stability tests across a range of storage conditions—not just room temperature—to assure end users that the compound arrives in workable condition.
For the solubility hurdle, innovative researchers are adopting streamlined solvent systems and solid-supported techniques. Using resin-bound coupling partners can speed up reaction workflows and reduce environmental impact. A key solution, which I’ve seen implemented to good effect, involves detailed protocols for workup and purification: optimized chromatographic methods that treat the bromine as a tag for easy product identification. These approaches help transform what could otherwise be a niche compound into a broadly useful tool.
Education makes a difference too. I’ve long promoted the importance of sharing lessons learned—both successes and failures—among teams. Collective experience with 7-Bromo-1H-Indazole, recorded in both published literature and internal reports, helps newer scientists leapfrog the trial-and-error phase. Better protocols and troubleshooting guides make for a more inclusive research climate, especially in interdisciplinary programs where chemists, biologists, and material scientists mingle.
Reflecting on years spent in the trenches of chemical research, I see 7-Bromo-1H-Indazole as more than a minor player or routine intermediate. Its adoption in both academic and commercial labs speaks to a larger trend—a search for adaptable, efficient building blocks that streamline the research and development pipeline. Rather than standing alone, this molecule often plays a pivotal supporting role in the story of modern drug discovery, catalysis, and even advanced materials.
A well-stocked chemical shelf tells a story: the presence of 7-Bromo-1H-Indazole shows both an openness to new methodologies and a commitment to efficiency. In an era driven by speed and innovation, investing in well-characterized, high-purity intermediates like this one pays off across the board. From speeding up lab-scale syntheses to supporting scalable commercial routes, experience has taught me that seemingly small differences in molecular structure can make all the difference in outcomes.
For chemists on the front line, the drive to solve problems outweighs any attachment to tradition. Over time, my own work—like that of many colleagues—has shifted toward adopting reagents that solve more problems and fewer that create new ones. 7-Bromo-1H-Indazole fits this mold, offering a blend of reactivity, predictability, and adaptability that keeps research moving. Its continued presence in scientific catalogs and growing literature only underscores the case for its widespread use.
As the field continues to evolve, real progress comes from the stories we share, the best practices we develop, and the incremental improvements that compounds like 7-Bromo-1H-Indazole make possible. Whether you’re building a new chemical library, designing a next-generation pharmaceutical, or troubleshooting your umpteenth reaction, the quality and characteristics of your starting materials matter. This molecule, in particular, stands out not just because of what it is, but because of what it makes possible for everyone willing to put in the work.